Severe bacterial infections in patients with non-transfusion-dependent thalassemia: prevalence and clinical risk factors

被引:35
作者
Teawtrakul, Nattiya [1 ]
Jetsrisuparb, Arunee [2 ]
Sirijerachai, Chittima [1 ]
Chansung, Kanchana [1 ]
Wanitpongpun, Chinadol [1 ]
机构
[1] Khon Kaen Univ, Srinagarind Hosp, Fac Med, Div Hematol,Dept Internal Med, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, Srinagarind Hosp, Fac Med, Div Hematol,Dept Pediat, Khon Kaen 40002, Thailand
关键词
Clinical risk factor; Bacterial infection; Non-transfusion-dependent thalassemia; BETA-THALASSEMIA; YERSINIA-ENTEROCOLITICA; IRON OVERLOAD; CHILDREN; DEFEROXAMINE; SURVIVAL; DESFERRIOXAMINE; COMPLICATIONS; DEFERIPRONE; DEFERASIROX;
D O I
10.1016/j.ijid.2015.09.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Bacterial infection is one of the major causes of death in patients with thalassemia. Clinical predictive factors for severe bacterial infection were evaluated in patients with non-transfusion-dependent thalassemia (NTDT). Methods: A retrospective study was conducted of patients with NTDT aged >= 10 years at Srinagarind Hospital, Khon Kaen University, Thailand. Clinical characteristics and potential clinical risk factors for bacterial infection were collected. Risk factors for bacterial infection were evaluated by multivariate logistic regression analysis. Results: A severe bacterial infection was found in 11 of the total 211 patients with NTDT (5.2%). None of the clinical factors assessed was shown to be statistically associated with severe bacterial infection in patients with NTDT. However, three factors were demonstrated to be potential predictive factors for severe bacterial infection: time after splenectomy > 10 years, deferoxamine therapy, and serum ferritin > 1000 ng/ml. None of the patients died from infection. Conclusion: The prevalence of bacterial infection in patients with NTDT was found to be moderate. Time after splenectomy > 10 years, deferoxamine therapy, and iron overload may be clinical risk factors for severe bacterial infection in patients with NTDT. Bacterial infection should be recognized in splenectomized patients with NTDT, particularly those who have an iron overload. (C) 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 28 条
[1]   SYSTEMIC YERSINIA-ENTEROCOLITICA INFECTION ASSOCIATED WITH IRON OVERLOAD AND DEFEROXAMINE THERAPY [J].
ABCARIAN, PW ;
DEMAS, BE .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1991, 157 (04) :773-775
[2]  
Aswapokee P, 1987, Birth Defects Orig Artic Ser, V23, P521
[3]   Survival and complications in thalassemia [J].
Borgna-Pignatti, C ;
Cappellini, MD ;
De Stefano, P ;
Del Vecchio, GC ;
Forni, GL ;
Gamberini, MR ;
Ghilardi, R ;
Origa, R ;
Piga, A ;
Romeo, MA ;
Zhao, H ;
Cnaan, A .
COOLEY'S ANEMIA EIGHTH SYMPOSIUM, 2005, 1054 :40-47
[4]   EFFECTS OF CHELATORS (DEFEROXAMINE, DEFERIPRONE AND DEFERASIROX) ON THE GROWTH OF KLEBSIELLA PNEUMONIAE AND AEROMONAS HYDROPHILA ISOLATED FROM TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS [J].
Chan, Godfrey Chi-Fung ;
Chan, Shing ;
Ho, Pak-Leung ;
Ha, Shau-Yin .
HEMOGLOBIN, 2009, 33 (05) :352-360
[5]   Survival, mortality, and complications in patients with β-thalassemia major in northern Taiwan [J].
Chern, Jimmy P. S. ;
Su, Syi ;
Lin, Kai-Hsin ;
Chang, Shu-Hui ;
Lu, Meng-Yao ;
Jou, Shiann-Tarng ;
Lin, Dong-Tsamn ;
Ho, Wan-Ling ;
Lin, Kuo-Sin .
PEDIATRIC BLOOD & CANCER, 2007, 48 (05) :550-554
[6]   T-LYMPHOCYTES AND IRON OVERLOAD - NOVEL CORRELATIONS OF POSSIBLE SIGNIFICANCE TO THE BIOLOGY OF THE IMMUNOLOGICAL SYSTEM [J].
DESOUSA, M .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1992, 87 :23-29
[7]  
Dua D, 1993, Indian Pediatr, V30, P893
[8]  
Issaragrisil S, 1987, Birth Defects Orig Artic Ser, V23, P505
[9]   T-CELL FUNCTIONS IN INFANTS AND CHILDREN WITH BETA-THALASSEMIA [J].
KHALIFA, AS ;
MAGED, Z ;
KHALIL, R ;
SABRI, F ;
HASSAN, O ;
ELALFY, M .
ACTA HAEMATOLOGICA, 1988, 79 (03) :153-156
[10]   Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica [J].
Lesic, B ;
Foulon, J ;
Carniel, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1741-1745